Cogstate
Cogstate Ltd is a neuroscience company focused on optimizing brain health assessments. They provide digital cognitive assessment tools and services for clinical trials, healthcare, and research, aiming to improve the detection and measurement of cognitive function. Their solutions support the development of new medicines and enable earlier clinical insights in healthcare.
Short position
Cogstate (ASX:CGS) has 0.03% of its shares on issue reported as short positions as of 5 Oct 2026, or about 46,761 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.81% in July 2023. CGS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Cogstate (CGS) short interest history
CGS Short Interest History
- 30-day change
- -0.00pp
- 90-day change
- -0.03pp
- 1-year change
- +0.03pp
- All-time high
- 0.81% (July 2023)
- All-time low
- 0.00% (November 2020)
Is CGS heavily shorted?
Not especially: 0.03% short interest is modest by ASX standards, ranking #531 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has CGS's short interest changed recently?
Over the past 30 days Cogstate's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.03% of shares on issue.
What is the highest CGS's short interest has been?
Since 2013, Cogstate's short interest peaked at 0.81% in July 2023 and bottomed at 0.00% in November 2020.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2013. See our methodology.